$ELTP Recent Headlines Former CEO of Elite

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ELTP Recent Headlines

Former CEO of Elite Pharmaceuticals sells all shares 10:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 4:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 5:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 12:07 p.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 1:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 2:27 p.m. Aug. 8, 2003 - Chris Kraeuter

Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 9:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 9:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 11:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 1:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 12:01 a.m. May 10, 2013 - InvestorPlace.com
Racket of Their Own 12:01 a.m. Aug. 15, 2006 - The Wall Street Journal Interactive Edition
Bristol Nears Approval on New Drug 12:01 a.m. Sept. 4, 2002 - The Wall Street Journal Interactive Edition
Market Movers Sink in First Half 6:32 p.m. July 1, 2002 - The Wall Street Journal Interactive Edition
Arthritis War Set to Commence 1:37 a.m. Nov. 10, 1998 - The Wall Street Journal Interactive Edition

Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 10:08 a.m. April 16, 2014 - ACCESSWIRE
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 10:03 a.m. April 16, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:02 a.m. April 15, 2014 - ACCESSWIRE
Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs 12:16 p.m. March 27, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine 8:05 a.m. March 24, 2014 - GlobeNewswire
Applied Materials Named a 2014 World's Most Ethical Company; KeyCorp Reported 2014 Company Run Stress Test Results and Process 12:29 a.m. March 21, 2014 - ACCESSWIRE
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally 7:47 a.m. March 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 8:31 a.m. March 5, 2014 - GlobeNewswire
BlackBerry May Power Ford's Future Generation Cars 5:48 a.m. Feb. 25, 2014 - ACCESSWIRE
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201 8:01 a.m. Feb. 18, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014 10:50 a.m. Feb. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014 4:27 p.m. Feb. 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc. 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
TrendingWallStreet.com Releases Updates on RFMD, EZPW, GFOX, and ELTP 1:17 a.m. Jan. 30, 2014 - ACCESSWIRE
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product 2:22 p.m. Jan. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201 1:50 p.m. Dec. 5, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Conversion of Treppel Bridge Loan to Convertible Note 8:00 a.m. Nov. 26, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014 5:23 p.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Second Quarter Business Update Call on November 18, 2013 8:45 a.m. Nov. 14, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 98

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 79

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 125

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 240

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 26

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 63

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 184

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading

Top 5 Most Recently Viewed Articles

California Science Center Celebrates Topping Out New Space Center

Updated Category News Views 338

California Science Center Celebrates Construction Milestone The California Science Center has recently achieved a remarkable milestone in the construction of the future Samuel Oschin Air and Space Center. The topping out ceremony celebrated the placement of some of the final steel beams in the innovative diagrid roof structure, which is set to become an iconic part of the...

Continue Reading
Analysis of Trump's Tax Proposal: Who Benefits Most?

Updated Category News Views 355

Trump's tax proposal hit the scene back in 2024, causing a storm of chatter among traders and economists. The thing was a mixed bag—while it looked like a goldmine for the wealthy, everyone else seemed to be left holding the short end of the stick. The Wealth Disparity Play: Tax Cuts or Tax Burdens? A detailed analysis from ITEP threw some serious numbers into the ring....

Continue Reading
MotherDuck Launches pg_duckdb to Revolutionize PostgreSQL Queries

Updated Category News Views 194

MotherDuck Introduces pg_duckdb for Enhanced Analytics MotherDuck is making waves in the data analytics world with the launch of its new PostgreSQL extension called pg_duckdb. This innovative tool brings the robust analytics capabilities of DuckDB right into the PostgreSQL environment, allowing businesses to execute sophisticated analytical queries without disrupting...

Continue Reading
Intel Corporation's Strategic Moves and Stock Performance Unveiled

Updated Category News Views 227

Intel Corporation's Latest Stock Surge Intel Corporation (NASDAQ: INTC) achieved an impressive stock gain of 4.84%, closing at $23.07 on a recent trading day. This surge reflects the company's vigorous restructuring efforts aimed at redefining its business operations. As industry dynamics shift, Intel is undergoing significant transformations to bolster its market...

Continue Reading
EagleView Introduces Comprehensive Property Data Ecosystem

Updated Category News Views 183

EagleView Brings Forth an Innovative Property Data Solution EagleView, a prominent player in aerial imagery, has unveiled its latest property data ecosystem, a significant leap forward in how property insights can be gathered and utilized. This new initiative encompasses over 60 petabytes of data, derived from high-definition aerial imagery, designed to provide invaluable...

Continue Reading